Benzinga | Aug 10, 2020 09:16AM EDT

Amicus Therapeutics Affirms FY2020 Sales Guidance from $250.00M-260.00M to $250.00M-260.00M

Amicus Therapeutics (NASDAQ:FOLD) affirms FY2020 sales outlook from $250.00 million-260.00 million to $250.00 million-260.00 million.